Learning lessons from the 2009 pandemic: Putting infections in their proper place

European Journal of Epidemiology

Volumn 26, Issue 3, 2011, Pages 191-194

  Nicoll, Angus ^a   Sprenger, Marc ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

2009 H1N1 INFLUENZA; ANALYSIS; CONFLICT OF INTEREST; DECISION MAKING; DISEASE SURVEILLANCE; EUROPE; HUMAN; INFECTION; INFLUENZA; MASS COMMUNICATION; MORTALITY; PANDEMIC; PLANNING; PUBLIC HEALTH; RESEARCH; REVIEW; SOCIAL STATUS; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

HEALTH POLICY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; WORLD HEALTH ORGANIZATION;

EID: 79955590744     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-011-9575-4     Document Type: Review

References (29)

1. Keil U, Schnfer P, Spelsberg A. The invention of the swine-flu pandemic. Eur J Epidemiol. 2011. (full citation to come).
2. Fineberg Preview of the Report of the Review Committee on the Functioning of the International Health Regulations (2005) and on pandemic influenza A (H1N1) 2009 March 2011. http://www.who.int/ihr/preview-report-review-committee- mar2011-en.pdf.
3. Nicoll A, McKee M. Moderate pandemic, not many dead. Learning the right lessons in Europe from the 2009 pandemic. EJPH. 2010;20(5):486-8. doi:10.1093/eurpub/ckq114 http://eurpub.oxfordjournals.org/content/20/5/486.full and http://eurpub.oxfordjournals.org/content/suppl/2010/09/27/ckq114.DC1/ ckq114-suppl.pdf.
4. Valenciano M Kissling E, Cohen J-M, Oroszi B, Barret AS, Rizzo C et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) Multicentre Case-Control Study. PLoS Med. 8(1):e1000388. doi:10.1371/journal. pmed.1000388 http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal. pmed.1000388.
5. Hongjie Yu, Qiaohong Liao, Yuan Yuan, Lei Zhou, Nijuan Xiang, Yang Huai et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ. 341. doi:10.1136/bmj.c4779 (Published 28 September 2010) http://www.bmj.com/content/341/bmj.c4779.full.pdf? html.
6. Nicoll A. Pandemic risk prevention in European countries: role of the ECDC in preparing for pandemics. Development and experience with a national self-assessment procedure, 2005-2008. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010;53(12):1267-75.
7. WHO checklist for influenza pandemic preparedness planning. WHO, Geneva. 2005. http://www.who.int/csr/resources/publications/influenza/FluCheck6web.pdf.
8. ECDC some suggested 'acid tests' for helping assess, strengthen local preparedness for moderate or severe pandemics. February 2007. http://www.ecdc.europa.eu/en/healthtopics/Documents/0702-Local-Assessment-Acid- Tests.pdf.
9. Leung G, Nicoll A. Initial reflections on pandemic A(H1N1) 2009 and the international response. Plos Med. 2010. http://www.plosmedicine.org/article/ info%3Adoi%2F10.1371%2Fjournal.pmed.1000346.
10. ECDC Pandemic 2009 evaluations and lessons learnt: listing. http://www.ecdc.europa.eu/en/healthtopics/H1N1/pandemic-2009-evaluations/Pages/ pandemic-2009-evaluations.aspx.
11. Flynn P. Social, health and family affairs committee. Parliamentary Assembly of the Council of Europe. The handling of the H1N1 pandemic: more transparency needed. 2010. http://assembly.coe.int/CommitteeDocs/2010/20100329- MemorandumPandemie-E.pdf.
12. European Parliament Committee on the Environment, Public Health and Food Safety Rapporteur: Michèle Rivasi on evaluation of the management of H1N1 influenza in 2009-2010 in the EU [2010/2153(INI)]. http://www.europarl.europa. eu/sides/getDoc.do?type=REPORT&reference=A7-2011-0035&language= EN&mode=XML.
13. ECDC & WHO Regional Office for Europe. Tuberculosis surveillance in Europe. 2009 (report). http://www.ecdc.europa.eu/en/publications/Publications/ 1103-TB-SUR-2009.pdf.
14. Murray CJL, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet. 2006;368:2211-8.
15. China Tuberculosis Control Collaboration. The effect of tuberculosis control in China. Lancet. 2004;364(9432):417-22.
16. Gopi PG, Subramani R, Narayanan PR. Trends in the prevalence of TB infection and ARTI after implementation of a DOTS programme in south India. Int J Tuberc Lung Dis. 2006;10(3): 346-8.
17. Marica C, Didilescu C, Galie N, Chiotan D, Zellweger JP, Sotgiu G, D'Ambrosio L, Centis R, Ditiu L, Migliori GB. Reversing the tuberculosis upwards trend: a success story in Romania. Eur Respir J. 2009;33(1):168-70.
18. Suk JE, Manissero D, Büscher G, Semenza JC. Wealth inequality and tuberculosis elimination in Europe. Emerg Infect Dis. 2009; 15(11):1812-4.
19. Steffens I, Martin R, Lopalco PL. Spotlight on measles 2010: measles elimination in Europe - a new commitment to meet the goal by 2015. Euro Surveill. 2010;15(50):pii=19749. Available at http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=19749.
20. Lopalco PL, Martin R. Measles still spreads in Europe: who is responsible for the failure to vaccinate? Euro Surveill. 2010; 15(17):pii=19557. Available at http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19557.
21. Muscat M, Bang H, Wohlfahrt J, Glismann S, Mølbak K and for the EUVAC.NET group. Measles in Europe: an epidemiological assessment. Lancet. 2009;373(9661):383-9. Epub 2009 Jan 7.
22. Carlsson RM, Trollfors B. Control of pertussis - Lessons learnt from a 10-year surveillance programme in Sweden. Vaccine. 2009;27(42):5709-18.
23. Godlee F. Institutional and editorial misconduct in the MMR scare. BMJ. 342:doi:10.1136/bmj.d378 http://www.bmj.com/content/342/bmj.d378.full?sid= 93cf23ff-2f0c-4504-8f67-1239fe6a1f3c.
24. Council of the European Union. Council Recommendation of 22 December 2009 on seasonal influenza vaccination (Text with EEA relevance) (2009/1019/EU). Off J Eur Union. 2009; L 348/71. Available at http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF.
25. Nicoll A, Ammon A, Amato Gauci A, Ciancio B, Zucs P, Devaux I, Plata F, Mazick A, Mølbak K, Asikainen T, Kramarz P. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health. 2010;124:14-23.
26. Neustadt RE, Fineberg HV. The swine flu affair: decision making on a slippery disease. Washington: US Department of Health, Education and Welfare; 1978.
27. Abraham T. The price of poor pandemic communication. BMJ. 2010. http://www.bmj.com/cgi/section-pdf/340/jun09-2/c2952.pdf.
28. Merecekiene J on behalf of the VENICE Consortium. Overview of pandemic A(H1N1) 2009 influenza vaccination in Europe. Preliminary results of survey conducted by VENICE. 2010. Presentation ESCAIDE Conference Lisbon November 13th 2010. http://ecdc.europa.eu/en/ESCAIDE/ESCAIDE%20Presentations%20library/ ESCAIDE2010-Late-Breakers-Mereckiene.pdf.
29. European Commission, Health protection agency, Crismart. Assessment report on EU-wide pandemic vaccine strategies. European Commission August 2010. http://ec.europa.eu/health/communicable-diseases/docs/assessment-vaccine-en.pdf